Who We Are
Compassionate Diagnostic Care
Future Diagnostic Services is a CLIA-certified laboratory specializing in advanced diagnostic testing, including pharmacogenetics, toxicology, and infectious disease analysis. We recognize the importance of compassionate, supportive care, and our team is committed to making every test as comfortable as possible, delivering each service with genuine empathy and professionalism.
Advanced Technology, Reliable Results
We believe that accuracy matters. By embracing the latest diagnostic technologies, we offer clear and timely medical assessments, giving healthcare providers and patients confidence and peace of mind.
Trusted Healthcare Partnerships
Building strong, respectful relationships is at the heart of what we do. We work closely with medical professionals to ensure seamless service, always striving to be a dependable partner in delivering the best possible care.
OUR SERVICES
Clinical Testing
Receive reliable and convenient clinical testing services, including blood tests, urinalysis, and other diagnostic evaluations. Focused on your well-being, we provide precise results you can trust with confidence.
On-Site Testing
Enjoy hassle-free on-site testing and bloodwork, as our skilled team delivers diagnostic services directly to your location for a smooth and convenient experience.
Genomics
Explore our genomic testing services, including pharmacogenomics, carrier screening, and NIPT. We deliver tailored insights to help you make well-informed decisions about your health.
Viral Testing
Our viral testing services include COVID-19, RPP, and STI panels, delivering precise results for your reassurance. Stay aware and protect your health with our dependable diagnostic solutions.
Toxicology Testing
Your well-being is our priority. With a compassionate approach to toxicology testing, we provide accurate results that help you make informed choices for a healthier future.
Genomic testing Technology
CGX (Cancer Genetic Testing):
Cancer Genomic Testing or Hereditary Cancer Testing.
Purpose: Identifies genetic mutations associated with a higher risk of developing cancers, often focusing on hereditary genes like BRCA1/BRCA2.Type: Germline (inherited) or somatic (tumor) testing.
PGX (Pharmacogenomics):
Testing that analyzes how a person's genetic makeup affects their response to medications.
Purpose: Helps doctors prescribe the right drug and dosage based on a patient's genetic profile (e.g., fast/slow metabolism of medicines) to improve efficacy and safety.
NIPT (Non-Invasive Prenatal Testing):
A screening test done on a maternal blood sample (after 10 weeks) that checks the cell-free DNA (cfDNA) of the placenta for chromosomal abnormalities.
Purpose: Screens for conditions like Down syndrome (Trisomy 21), Trisomy 18, Trisomy 13, and sex chromosome aneuploidies. It is a genomic screening, not a diagnostic test.
UTI (Urinary Tract Infection Molecular Testing):
Often called "Molecular UTI testing" or Urinary Tract Microbiota (UTM) analysis.
Purpose: Uses molecular methods (like qPCR or next-generation sequencing) to identify the specific pathogens (bacteria or fungi) causing a UTI, which is faster and more accurate than traditional urine cultures.